ATEX vs GOGO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, signaling significant operational and profitability concerns. Despite a low P/E of 4.72 and a Graham Number of $38.17 suggesting undervaluation, the negative forward P/E, erratic earnings, and extremely high reported profit margin of 1614% indicate unreliable profitability metrics. The stock trades well below analyst target of $55.33, but weak revenue growth, negative operating margins, and bearish insider activity raise sustainability concerns. Technical trend at 0/100 and declining long-term price performance further support a cautious outlook.
GOGO exhibits a precarious financial profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a critical Debt/Equity ratio of 8.96. While revenue growth is exceptionally strong at 67.3%, this is decoupled from earnings, which have plummeted -116.7% YoY. The stock trades at a significant premium to its Graham Number ($1.3) and Intrinsic Value ($0.7), while the technical trend remains entirely bearish. The combination of extreme leverage and consistent earnings misses outweighs the top-line growth potential.
Compare Another Pair
Related Comparisons
ATEX vs GOGO: Head-to-Head Comparison
This page compares Anterix Inc. (ATEX) and Gogo Inc. (GOGO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.